Chimerix (NASDAQ: CMRX) reported Q2 EPS of ($0.23), in-line with the analyst estimate of ($0.23). Revenue for the quarter came in at $129 thousand versus the consensus estimate of $630 thousand.

For earnings history and earnings-related data on Chimerix (CMRX) click here.